IPSS quality of life question: A possible indicator of depression among patients with lower urinary tract symptoms

Timothy V. Johnson, Ammara Abbasi, Samantha S. Ehrlich, Renee S. Kleris, Ashli Owen-Smith, Charles L Raison, Viraj A. Master

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Introduction: Depression and benign prostatic hyperplasia (BPH) are prevalent, especially in older patient populations. Emerging data suggest potential interactions between depression and BPH. We sought to assess whether the questions of the International Prostate Symptom Score (IPSS), specifically the quality of life (QoL) question, predict depression. Materials and methods: We asked 541 consecutive male patients over the age of 40 in a tertiary care clinic to self-administer the IPSS QoL score and the Geriatric Depression Scale (GDS), a validated screening tool for depression. Receiver operating characteristics (ROC) curves were depicted and used to determine the area under the curve (AUC) and relative sensitivity and specificity of the individual questions of the IPSS relative to the GDS. Results: Of the cohort, 17.2 percent screened positive for depression. More than half (54.7%) of nondepressed patients had a QoL score of 0-2, while a similar number of depressed patients (50.8%) had a QoL score of 5 or 6. The QoL question of the IPSS exhibited an AUC (95% CI, p value) of 0.735 (0.669-0.800, p < 0.001). A cut-offof QoL scores > 5 exhibited the highest specificity (93.1%)while a cut offof QoL scores > 1 exhibited a sensitivity of 90.0%. Conclusions: Future studies should validate these findings and shed further light on this tool's clinical utility. Pending this future validation, patients with a score of 6 could be considered for further mental health evaluation.

Original languageEnglish (US)
Pages (from-to)6100-6104
Number of pages5
JournalCanadian Journal of Urology
Volume19
Issue number1
StatePublished - 2012
Externally publishedYes

Fingerprint

Lower Urinary Tract Symptoms
Prostate
Quality of Life
Depression
Prostatic Hyperplasia
Geriatrics
Area Under Curve
Tertiary Healthcare
ROC Curve
Mental Health
Sensitivity and Specificity
Population

Keywords

  • Lower urinary tract symptoms
  • Major depressive disorder

ASJC Scopus subject areas

  • Urology

Cite this

Johnson, T. V., Abbasi, A., Ehrlich, S. S., Kleris, R. S., Owen-Smith, A., Raison, C. L., & Master, V. A. (2012). IPSS quality of life question: A possible indicator of depression among patients with lower urinary tract symptoms. Canadian Journal of Urology, 19(1), 6100-6104.

IPSS quality of life question : A possible indicator of depression among patients with lower urinary tract symptoms. / Johnson, Timothy V.; Abbasi, Ammara; Ehrlich, Samantha S.; Kleris, Renee S.; Owen-Smith, Ashli; Raison, Charles L; Master, Viraj A.

In: Canadian Journal of Urology, Vol. 19, No. 1, 2012, p. 6100-6104.

Research output: Contribution to journalArticle

Johnson, TV, Abbasi, A, Ehrlich, SS, Kleris, RS, Owen-Smith, A, Raison, CL & Master, VA 2012, 'IPSS quality of life question: A possible indicator of depression among patients with lower urinary tract symptoms', Canadian Journal of Urology, vol. 19, no. 1, pp. 6100-6104.
Johnson, Timothy V. ; Abbasi, Ammara ; Ehrlich, Samantha S. ; Kleris, Renee S. ; Owen-Smith, Ashli ; Raison, Charles L ; Master, Viraj A. / IPSS quality of life question : A possible indicator of depression among patients with lower urinary tract symptoms. In: Canadian Journal of Urology. 2012 ; Vol. 19, No. 1. pp. 6100-6104.
@article{dc3ba066566f41aa947de82fbe6b1712,
title = "IPSS quality of life question: A possible indicator of depression among patients with lower urinary tract symptoms",
abstract = "Introduction: Depression and benign prostatic hyperplasia (BPH) are prevalent, especially in older patient populations. Emerging data suggest potential interactions between depression and BPH. We sought to assess whether the questions of the International Prostate Symptom Score (IPSS), specifically the quality of life (QoL) question, predict depression. Materials and methods: We asked 541 consecutive male patients over the age of 40 in a tertiary care clinic to self-administer the IPSS QoL score and the Geriatric Depression Scale (GDS), a validated screening tool for depression. Receiver operating characteristics (ROC) curves were depicted and used to determine the area under the curve (AUC) and relative sensitivity and specificity of the individual questions of the IPSS relative to the GDS. Results: Of the cohort, 17.2 percent screened positive for depression. More than half (54.7{\%}) of nondepressed patients had a QoL score of 0-2, while a similar number of depressed patients (50.8{\%}) had a QoL score of 5 or 6. The QoL question of the IPSS exhibited an AUC (95{\%} CI, p value) of 0.735 (0.669-0.800, p < 0.001). A cut-offof QoL scores > 5 exhibited the highest specificity (93.1{\%})while a cut offof QoL scores > 1 exhibited a sensitivity of 90.0{\%}. Conclusions: Future studies should validate these findings and shed further light on this tool's clinical utility. Pending this future validation, patients with a score of 6 could be considered for further mental health evaluation.",
keywords = "Lower urinary tract symptoms, Major depressive disorder",
author = "Johnson, {Timothy V.} and Ammara Abbasi and Ehrlich, {Samantha S.} and Kleris, {Renee S.} and Ashli Owen-Smith and Raison, {Charles L} and Master, {Viraj A.}",
year = "2012",
language = "English (US)",
volume = "19",
pages = "6100--6104",
journal = "Canadian Journal of Urology",
issn = "1195-9479",
publisher = "Canadian Journal of Urology",
number = "1",

}

TY - JOUR

T1 - IPSS quality of life question

T2 - A possible indicator of depression among patients with lower urinary tract symptoms

AU - Johnson, Timothy V.

AU - Abbasi, Ammara

AU - Ehrlich, Samantha S.

AU - Kleris, Renee S.

AU - Owen-Smith, Ashli

AU - Raison, Charles L

AU - Master, Viraj A.

PY - 2012

Y1 - 2012

N2 - Introduction: Depression and benign prostatic hyperplasia (BPH) are prevalent, especially in older patient populations. Emerging data suggest potential interactions between depression and BPH. We sought to assess whether the questions of the International Prostate Symptom Score (IPSS), specifically the quality of life (QoL) question, predict depression. Materials and methods: We asked 541 consecutive male patients over the age of 40 in a tertiary care clinic to self-administer the IPSS QoL score and the Geriatric Depression Scale (GDS), a validated screening tool for depression. Receiver operating characteristics (ROC) curves were depicted and used to determine the area under the curve (AUC) and relative sensitivity and specificity of the individual questions of the IPSS relative to the GDS. Results: Of the cohort, 17.2 percent screened positive for depression. More than half (54.7%) of nondepressed patients had a QoL score of 0-2, while a similar number of depressed patients (50.8%) had a QoL score of 5 or 6. The QoL question of the IPSS exhibited an AUC (95% CI, p value) of 0.735 (0.669-0.800, p < 0.001). A cut-offof QoL scores > 5 exhibited the highest specificity (93.1%)while a cut offof QoL scores > 1 exhibited a sensitivity of 90.0%. Conclusions: Future studies should validate these findings and shed further light on this tool's clinical utility. Pending this future validation, patients with a score of 6 could be considered for further mental health evaluation.

AB - Introduction: Depression and benign prostatic hyperplasia (BPH) are prevalent, especially in older patient populations. Emerging data suggest potential interactions between depression and BPH. We sought to assess whether the questions of the International Prostate Symptom Score (IPSS), specifically the quality of life (QoL) question, predict depression. Materials and methods: We asked 541 consecutive male patients over the age of 40 in a tertiary care clinic to self-administer the IPSS QoL score and the Geriatric Depression Scale (GDS), a validated screening tool for depression. Receiver operating characteristics (ROC) curves were depicted and used to determine the area under the curve (AUC) and relative sensitivity and specificity of the individual questions of the IPSS relative to the GDS. Results: Of the cohort, 17.2 percent screened positive for depression. More than half (54.7%) of nondepressed patients had a QoL score of 0-2, while a similar number of depressed patients (50.8%) had a QoL score of 5 or 6. The QoL question of the IPSS exhibited an AUC (95% CI, p value) of 0.735 (0.669-0.800, p < 0.001). A cut-offof QoL scores > 5 exhibited the highest specificity (93.1%)while a cut offof QoL scores > 1 exhibited a sensitivity of 90.0%. Conclusions: Future studies should validate these findings and shed further light on this tool's clinical utility. Pending this future validation, patients with a score of 6 could be considered for further mental health evaluation.

KW - Lower urinary tract symptoms

KW - Major depressive disorder

UR - http://www.scopus.com/inward/record.url?scp=84862268102&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862268102&partnerID=8YFLogxK

M3 - Article

C2 - 22316511

AN - SCOPUS:84862268102

VL - 19

SP - 6100

EP - 6104

JO - Canadian Journal of Urology

JF - Canadian Journal of Urology

SN - 1195-9479

IS - 1

ER -